The potential utility of some legal highs in CNS disorders

作者: Colin Davidson , Fabrizio Schifano

DOI: 10.1016/J.PNPBP.2015.07.010

关键词:

摘要: Over the last decade there has been an explosion of new drugs abuse, so called legal highs or novel psychoactive substances (NPS). Many these abused have unknown pharmacology, but their biological effects can be anticipated from molecular structure and possibly also online user reports. When considered with findings that some prescription medications are increasingly tested clinically one could argue a blurring line between abuse used drugs. In this review we examine highs/NPS consider whether, based on known predicted might potential to useful in CNS disorders.

参考文章(152)
Jules Angst, Gabriele Stotz, Brigitte Woggon, Psychostimulants in the therapy of treatment-resistant depression Review of the literature and findings from a retrospective study in 65 depressed patients. Dialogues in clinical neuroscience. ,vol. 1, pp. 165- 174 ,(1999)
Timothy Roehrs, Ardith Zwyghuizen-Doorenbos, Thomas Roth, Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo. Sleep. ,vol. 16, pp. 301- 305 ,(1993) , 10.1093/SLEEP/16.4.301
Duccio Papanti, Fabrizio Schifano, Giulia Botteon, Francesca Bertossi, Jason Mannix, Daniela Vidoni, Matteo Impagnatiello, Elisabetta Pascolo-Fabrici, Tommaso Bonavigo, “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report Human Psychopharmacology-clinical and Experimental. ,vol. 28, pp. 379- 389 ,(2013) , 10.1002/HUP.2312
Di Gu, Jun Huang, Zhengfei Shan, Youle Yin, Shaobin Zheng, Peng Wu, Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system. International Journal of Urology. ,vol. 20, pp. 1024- 1031 ,(2013) , 10.1111/IJU.12100
Scott Wilkes, The use of bupropion SR in cigarette smoking cessation. International Journal of Chronic Obstructive Pulmonary Disease. ,vol. 3, pp. 45- 53 ,(2008) , 10.2147/COPD.S1121
Brian E. McGeeney, Hallucinogens and Cannabinoids for Headache Headache. ,vol. 52, pp. 94- 97 ,(2012) , 10.1111/J.1526-4610.2012.02245.X
Bjoern Moosmann, Leslie A. King, Volker Auwärter, Designer benzodiazepines: A new challenge. World Psychiatry. ,vol. 14, pp. 248- 248 ,(2015) , 10.1002/WPS.20236
Marta Duran, Eulàlia Pérez, Sergio Abanades, Xavier Vidal, Cristina Saura, Margarita Majem, Edurne Arriola, Manel Rabanal, Antoni Pastor, Magí Farré, Neus Rams, Joan-Ramon Laporte, Dolors Capellà, Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting British Journal of Clinical Pharmacology. ,vol. 70, pp. 656- 663 ,(2010) , 10.1111/J.1365-2125.2010.03743.X
Hamilton Morris, Jason Wallach, From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs Drug Testing and Analysis. ,vol. 6, pp. 614- 632 ,(2014) , 10.1002/DTA.1620